Ready to leave?
Oops ! Condition name you have entered is invalid.
You are now leaving Aposbook.com and going to an external site managed by another organization.
Please confirm your email address and try to login again.
This account has been deleted. do you want to restore it?
A verification link will be sent to within the next 2 minutes. Please click it to validate your e mail.
*If you didn't get the link, please check your spam folder
As a registered user, you can benefit from the various free tools and services that we provide.
All you need to do is log in to start discussing with others, interacting, asking questions, and sharing your point of view about the various topics.
You can also write reviews and testimonials about any natural solution you have tried and share your experience. Your feedback can be very helpful.
If you are a health expert, you can add information about any topic or suggest text edit. You can also publish content, including articles and videos, about any topic from the related library section.
Together we can help.
The Aposbook Team
A validation link will be sent to you by email. Please confirm your address to log in
*If you didn't get the link, please check your spam folder
Please log in to use this feature
Your account has been suspended because you have violated our code of conduct. If you think this was a mistake, you can contact us by email at: support@aposbook.com "Contact us" form.
Success! Thank you for your feedback. Your contribution can make a difference. Together we can help each other.
Khattab Al-Khafaji & Tugba Taskin Tok
Published online: 09 Mar 2020
Abstract
Amygdalin possesses anticancer properties and induces apoptosis. Based on experimental studies the presence of amygdalin with cancer cells led to activate the caspase-3 and BAX and inhibits Bcl-2 and Poly (ADP-ribose) polymerase-1 (PARP-1) but without deep information on action mode of these activities.
Herein, we leaped forward to examine the molecular dynamics of the bound amygdalin and free ligand proteins, to identify precise action (conformation changes in targeted proteins) of amygdalin through using double docking and molecular dynamics (MD) simulations for 50 ns time scale.
The MD simulations revealed that the binding of amygdalin led to disrupting the interaction between the Bcl-2/BAX complex. We furthermore conducted MD simulation for Bcl-2/amygdalin to investigate the stability of the complex which is responsible for inhibition of Bcl-2. It has been obtained a stable Bcl-2/amygdalin complex during the 50 ns.
The results give a detail explanation of how amygdalin activates BAX and inhibits Bcl-2. For caspase-3, the matter is different, we found that amygdalin led to disrupting the interaction of caspase-3’s two chains for intervals during 50 ns and then bind together repeatedly.
The mechanism of caspase-3’s activation through switching by disrupt the interacts for periodic intervals manner. For PARP-1, the dynamics simulations results indicated amygdalin interacts with PARP-1’s binding site and forms stable interaction during simulation to render it inactive.
Hence, amygdalin revealed a supernatural behavior through the MD simulations: it revealed a further clarification of the mystery amygdalin’s experimental action which can act as a multifunctional drug in the cancer therapeutics.
Communicated by Ramaswamy H. Sarma
Laetrile/Amygdalin (PDQ®)
Review on Pharmacological Activity of Amygdalin